Volume 1 · Issue 2

Precision Neurology

Clinical research on diagnosis, classification and biomarkers across epilepsy, neuroimmunology, headache and disorders of the peripheral nervous system.

100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief

Issue 2 · Reading list

Explore the research

Download issue catalog

100 readings · Page 3 of 5

  1. Headache and migraine · CC BY 4.0

    Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial.

    Andreas Straube, J Ellrich, O Eren, B Blum et al.

    The journal of headache and pain · 2015

    Original article
  2. Headache and migraine · CC BY 4.0

    IL-17 crosses the blood-brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine.

    Hao Chen, Xueqian Tang, Jin Li, Bangyan Hu et al.

    The journal of headache and pain · 2022

    Original article
  3. Headache and migraine · CC BY 4.0

    Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.

    Daniel Serrano, Richard B Lipton, Ann I Scher, Michael L Reed et al.

    The journal of headache and pain · 2017

    Original article
  4. Headache and migraine · CC BY 4.0

    MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model.

    Qianwen Wen, Yunfeng Wang, Qi Pan, Ruimin Tian et al.

    Journal of neuroinflammation · 2021

    Original article
  5. Headache and migraine · CC BY 4.0

    A prospective real-world analysis of erenumab in refractory chronic migraine.

    Giorgio Lambru, Bethany Hill, Madeleine Murphy, Ivona Tylova et al.

    The journal of headache and pain · 2020

    Original article
  6. Headache and migraine · CC BY 4.0

    Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.

    Andrew M Blumenfeld, Richard J Stark, Marshall C Freeman, Amelia Orejudos et al.

    The journal of headache and pain · 2018

    Original article
  7. Headache and migraine · CC BY 4.0

    Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine.

    Regina Rendas-Baum, Min Yang, Sepideh F Varon, Lisa M Bloudek et al.

    Health and quality of life outcomes · 2014

    Original article
  8. Headache and migraine · CC BY 4.0

    Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).

    Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa et al.

    The journal of headache and pain · 2021

    Original article
  9. Headache and migraine · CC BY 4.0

    Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study.

    Piero Barbanti, Licia Grazzi, Gabriella Egeo, Anna Maria Padovan et al.

    The journal of headache and pain · 2015

    Original article
  10. Headache and migraine · CC BY 4.0

    Current and emerging evidence-based treatment options in chronic migraine: a narrative review.

    Elio Clemente Agostoni, Piero Barbanti, Paolo Calabresi, Bruno Colombo et al.

    The journal of headache and pain · 2019

    Original article
  11. Headache and migraine · CC BY 4.0

    P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.

    Feng Jing, Yixin Zhang, Ting Long, Wei He et al.

    Journal of neuroinflammation · 2019

    Original article
  12. Headache and migraine · CC BY 4.0

    Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation.

    Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos Mitsikostas et al.

    The journal of headache and pain · 2018

    Original article
  13. Headache and migraine · CC BY 4.0

    Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study.

    Mi Ji Lee, Bo-Yong Park, Soohyun Cho, Sung Tae Kim et al.

    The journal of headache and pain · 2019

    Original article
  14. Headache and migraine · CC BY 4.0

    P2X7R-mediated autophagic impairment contributes to central sensitization in a chronic migraine model with recurrent nitroglycerin stimulation in mice.

    Li Jiang, Yixin Zhang, Feng Jing, Ting Long et al.

    Journal of neuroinflammation · 2021

    Original article
  15. Headache and migraine · CC BY 4.0

    Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation.

    Dimos D Mitsikostas, Lars Edvinsson, Rigmor H Jensen, Zaza Katsarava et al.

    The journal of headache and pain · 2014

    Original article
  16. Headache and migraine · CC BY 4.0

    Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

    Modar Khalil, Hassan W Zafar, Victoria Quarshie, Fayyaz Ahmed

    The journal of headache and pain · 2014

    Original article
  17. Headache and migraine · CC BY 4.0

    Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model.

    Ting Long, Wei He, Qi Pan, Shanshan Zhang et al.

    The journal of headache and pain · 2020

    Original article
  18. Headache and migraine · CC BY 4.0

    Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives.

    Tiffani J Mungoven, Luke A Henderson, Noemi Meylakh

    Frontiers in pain research (Lausanne, Switzerland) · 2021

    Original article
  19. Headache and migraine · CC BY 4.0

    The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.

    Stephen D Silberstein, Joshua M Cohen, Michael J Seminerio, Ronghua Yang et al.

    The journal of headache and pain · 2020

    Original article
  20. Headache and migraine · CC BY 4.0

    Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience.

    Antonio Russo, Marcello Silvestro, Fabrizio Scotto di Clemente, Francesca Trojsi et al.

    The journal of headache and pain · 2020

    Original article